GR852864B - - Google Patents
Info
- Publication number
- GR852864B GR852864B GR852864A GR850102864A GR852864B GR 852864 B GR852864 B GR 852864B GR 852864 A GR852864 A GR 852864A GR 850102864 A GR850102864 A GR 850102864A GR 852864 B GR852864 B GR 852864B
- Authority
- GR
- Greece
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/82—Translation products from oncogenes
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
- C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
- C12Q1/6886—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
- G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
- G01N33/5014—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics for testing toxicity
- G01N33/5017—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics for testing toxicity for testing neoplastic activity
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/118—Prognosis of disease development
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Organic Chemistry (AREA)
- Immunology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Molecular Biology (AREA)
- Genetics & Genomics (AREA)
- Analytical Chemistry (AREA)
- Biochemistry (AREA)
- Pathology (AREA)
- General Health & Medical Sciences (AREA)
- Biomedical Technology (AREA)
- Zoology (AREA)
- Microbiology (AREA)
- Biotechnology (AREA)
- Wood Science & Technology (AREA)
- Biophysics (AREA)
- Physics & Mathematics (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Urology & Nephrology (AREA)
- Oncology (AREA)
- Hematology (AREA)
- Medicinal Chemistry (AREA)
- Toxicology (AREA)
- Tropical Medicine & Parasitology (AREA)
- Hospice & Palliative Care (AREA)
- Cell Biology (AREA)
- Gastroenterology & Hepatology (AREA)
- General Engineering & Computer Science (AREA)
- Food Science & Technology (AREA)
- General Physics & Mathematics (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Peptides Or Proteins (AREA)
- Saccharide Compounds (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Investigating Or Analysing Biological Materials (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US67662584A | 1984-11-30 | 1984-11-30 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| GR852864B true GR852864B (instruction) | 1986-03-28 |
Family
ID=24715276
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| GR852864A GR852864B (instruction) | 1984-11-30 | 1985-11-27 |
Country Status (13)
| Country | Link |
|---|---|
| EP (1) | EP0203970A1 (instruction) |
| JP (1) | JPS62501399A (instruction) |
| AU (1) | AU5197986A (instruction) |
| DK (1) | DK359486A (instruction) |
| ES (1) | ES8705043A1 (instruction) |
| FI (1) | FI863095A0 (instruction) |
| GR (1) | GR852864B (instruction) |
| HU (1) | HUT41837A (instruction) |
| IL (1) | IL77157A0 (instruction) |
| NO (1) | NO863066L (instruction) |
| PT (1) | PT81584B (instruction) |
| WO (1) | WO1986003226A1 (instruction) |
| ZA (1) | ZA859070B (instruction) |
Families Citing this family (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5049662A (en) * | 1987-10-13 | 1991-09-17 | The United States Of America As Represented By The Department Of Health And Human Services | Kit for diagnosing cancer metastatic potential |
| ES2164634T3 (es) * | 1989-10-18 | 2002-03-01 | Us Health | Produccion y uso de proteina nm23-h2 humana y anticuerpos previstos a tal efecto. |
| US5633161A (en) * | 1995-03-29 | 1997-05-27 | Millennium Pharmaceuticals, Inc. | Murine gene fomy030 coding for tumor progression inhibitor |
| US6794185B1 (en) | 1995-03-29 | 2004-09-21 | Millennium Pharmaceuticals, Inc. | fohy030 nucleic acid molecules |
| US6825320B1 (en) | 1995-03-29 | 2004-11-30 | Millenium Pharmaceuticals, Inc. | FOHY03 polypeptides |
| US6251597B1 (en) | 1996-03-29 | 2001-06-26 | Millennium Pharmaceuticals, Inc. | Methods for detecting fohy030 |
| US5783182A (en) * | 1996-01-30 | 1998-07-21 | Baylor College Of Medicine | Method for identifying metastatic sequences |
| WO1997018454A2 (en) * | 1995-11-16 | 1997-05-22 | Baylor College Of Medicine | Method for identifying metastatic sequences |
| USRE38490E1 (en) | 1995-11-16 | 2004-04-06 | Baylor College Of Medicine | Method for identifying metastatic sequences |
| WO1997025443A1 (en) * | 1996-01-10 | 1997-07-17 | The University Of Liverpool | Metastasis inducing dna's |
| USRE38392E1 (en) | 1996-01-30 | 2004-01-20 | Baylor College Of Medicine | Method for identifying metastatic sequences |
| US6312909B1 (en) | 1996-03-29 | 2001-11-06 | Millennium Pharmaceuticals, Inc. | Compositions and methods for the diagnosis prevention and treatment of tumor progression |
| US6252058B1 (en) | 1997-11-05 | 2001-06-26 | Timothy C. Thompson | Sequences for targeting metastatic cells |
| WO1999046385A2 (en) | 1998-03-13 | 1999-09-16 | Baylor College Of Medicine | Compositions and methods for the treatment and prevention of metastatic disorders |
| US7462491B2 (en) | 2002-01-31 | 2008-12-09 | Baylor College Of Medicine | Methods and compositions for diagnosis and monitoring of prostate cancer progression by detection of serum caveolin |
-
1985
- 1985-11-26 AU AU51979/86A patent/AU5197986A/en not_active Abandoned
- 1985-11-26 IL IL77157A patent/IL77157A0/xx unknown
- 1985-11-26 HU HU8667A patent/HUT41837A/hu unknown
- 1985-11-26 EP EP85906133A patent/EP0203970A1/en not_active Withdrawn
- 1985-11-26 JP JP60505382A patent/JPS62501399A/ja active Pending
- 1985-11-26 FI FI863095A patent/FI863095A0/fi not_active IP Right Cessation
- 1985-11-26 WO PCT/US1985/002323 patent/WO1986003226A1/en not_active Application Discontinuation
- 1985-11-27 GR GR852864A patent/GR852864B/el unknown
- 1985-11-27 ZA ZA859070A patent/ZA859070B/xx unknown
- 1985-11-29 PT PT81584A patent/PT81584B/pt unknown
- 1985-11-29 ES ES549438A patent/ES8705043A1/es not_active Expired
-
1986
- 1986-07-29 NO NO863066A patent/NO863066L/no unknown
- 1986-07-29 DK DK359486A patent/DK359486A/da not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| NO863066D0 (no) | 1986-07-29 |
| PT81584B (en) | 1987-04-07 |
| PT81584A (en) | 1985-12-01 |
| ZA859070B (en) | 1986-07-30 |
| NO863066L (no) | 1986-09-29 |
| JPS62501399A (ja) | 1987-06-11 |
| FI863095L (fi) | 1986-07-29 |
| DK359486D0 (da) | 1986-07-29 |
| DK359486A (da) | 1986-07-29 |
| AU5197986A (en) | 1986-06-18 |
| ES8705043A1 (es) | 1987-04-16 |
| ES549438A0 (es) | 1987-04-16 |
| WO1986003226A1 (en) | 1986-06-05 |
| FI863095A7 (fi) | 1986-07-29 |
| HUT41837A (en) | 1987-05-28 |
| FI863095A0 (fi) | 1986-07-29 |
| IL77157A0 (en) | 1986-04-29 |
| EP0203970A1 (en) | 1986-12-10 |